More than 100 million people across Europe suffer from chronic musculoskeletal pain, with an estimated 40 percent undiagnosed.

Ageing populations throughout Europe means that this is only going to increase in the coming years.

To help address this issue a team of technical engineers and physiotherapy experts from across Europe have come together to develop a solution that will aid the speed and quality of treatment by physiotherapists and related professionals.

The result is the Intelligent Motion Analysis (IMA) device, which for the first time, will allow physiotherapists to quantitatively track and monitor patient developments without having to refer patients to clinicians and consultants.

The device, which cost £2.8 million to develop, is the first of its kind to track both the range of motion of joints and the electromyography of the muscles needed to generate movement.

It is expected that the IMA will rapidly improve the speed and accuracy of diagnosis and treatment.

The overall aim of the Intelligent Motion Analysis device is to improve treatment for patients, while at the same time alleviating the burden on health care systems and businesses.

Source: http://www.peratechnology.com/